Created with an expert scientific advisory board, SMi’s 17th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research.
Aimed at an audience of scientific leaders and senior specialists in neuroscience, CNS, clinical operations and pharmacology, Pain Therapeutics 2017 will keep attendees at the forefront of medical breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery.
Presentations from a selection of hand-picked pharmaceutical companies currently developing novel treatments in pain, will provide delegates with an understanding on key topics such as product formulation; opioid addiction; translational pain research; and breakthroughs in drug discovery.
Interactive workshops and exclusive new findings from phase II clinical trials will be just some of the highlights at the 17th annual show when it returns to London this spring.
KEYNOTE SPEAKERS INCLUDE:
The packed agenda also features talks from Lilly UK, Novartis, Pharmaleads, Mundipharma Research and more!
REASONS TO ATTEND IN 2017
Visit the website for further details at http://www.pain-therapeutics.co.uk/euagenda or contact the team on +44 (0)20 7827 6000 / email: firstname.lastname@example.org
22 May 2017 @ 12:00 am
23 May 2017 @ 12:01 am
Duration: 1 days
Copthorne Tara Hotel
1 Scarsdale Place